![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1304753 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of PCDH17 mRNA | CTD | PMID:30723492 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1304753 | 6480464 | Ethinyl Estradiol results in increased expression of PCDH17 mRNA | CTD | PMID:29097150 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:1304753 | 6480464 | 2 more ... | CTD | PMID:21394737 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1617378 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCDH17 mRNA | CTD | PMID:21570461 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1304753 | 6480464 | Propylthiouracil results in increased expression of PCDH17 mRNA | CTD | PMID:24780913 | acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PCDH17 mRNA | CTD | PMID:11906190 | acrylamide | decreases expression | ISO | RGD:1304753 | 6480464 | Acrylamide results in decreased expression of PCDH17 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:1304753 | 6480464 | Aflatoxin B1 results in increased expression of PCDH17 mRNA | CTD | PMID:23630614 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PCDH17 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PCDH17 mRNA | CTD | PMID:21934132, PMID:23724009 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of PCDH17 mRNA | CTD | PMID:24449571 | arsane | decreases expression | ISO | RGD:1617378 | 6480464 | Arsenic results in decreased expression of PCDH17 mRNA | CTD | PMID:19654921 | arsenic atom | decreases expression | ISO | RGD:1617378 | 6480464 | Arsenic results in decreased expression of PCDH17 mRNA | CTD | PMID:19654921 | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of PCDH17 promoter | CTD | PMID:23974009 | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein] | CTD | PMID:26598702 | astemizole | decreases expression | ISO | RGD:1304753 | 6480464 | Astemizole results in decreased expression of PCDH17 mRNA | CTD | PMID:20221588 | benzo[a]pyrene | decreases expression | ISO | RGD:1617378 | 6480464 | Benzo(a)pyrene results in decreased expression of PCDH17 mRNA | CTD | PMID:21569818, PMID:22228805 | benzo[a]pyrene | multiple interactions | ISO | RGD:1617378 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases expression | ISO | RGD:1617378 | 6480464 | Benzo(a)pyrene results in increased expression of PCDH17 mRNA | CTD | PMID:21964900, PMID:22610609 | benzo[b]fluoranthene | increases expression | ISO | RGD:1617378 | 6480464 | benzo(b)fluoranthene results in increased expression of PCDH17 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1617378 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | ISO | RGD:1617378 | 6480464 | bisphenol A results in decreased expression of PCDH17 mRNA | CTD | PMID:26063408 | bisphenol A | affects expression | ISO | RGD:1304753 | 6480464 | bisphenol A affects the expression of PCDH17 mRNA | CTD | PMID:25181051 | C60 fullerene | increases expression | ISO | RGD:1304753 | 6480464 | fullerene C60 results in increased expression of PCDH17 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases expression | ISO | RGD:1304753 | 6480464 | Cadmium Chloride results in increased expression of PCDH17 mRNA | CTD | PMID:25993096 | carbon nanotube | increases expression | ISO | RGD:1617378 | 6480464 | Nanotubes, Carbon analog results in increased expression of PCDH17 mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | RGD:1617378 | 6480464 | Nanotubes, Carbon results in decreased expression of PCDH17 mRNA | CTD | PMID:25554681, PMID:25620056 | chloroprene | increases expression | ISO | RGD:1304753 | 6480464 | Chloroprene results in increased expression of PCDH17 mRNA | CTD | PMID:23125180 | chrysene | multiple interactions | ISO | RGD:1617378 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | clobetasol | decreases expression | ISO | RGD:1617378 | 6480464 | Clobetasol results in decreased expression of PCDH17 mRNA | CTD | PMID:27462272 | copper atom | increases expression | ISO | RGD:1304753 | 6480464 | Copper deficiency results in increased expression of PCDH17 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | ISO | RGD:1304753 | 6480464 | Copper deficiency results in increased expression of PCDH17 mRNA | CTD | PMID:26033743 | decabromodiphenyl ether | increases expression | ISO | RGD:1304753 | 6480464 | decabromobiphenyl ether results in increased expression of PCDH17 mRNA | CTD | PMID:23640034 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein] | CTD | PMID:26598702 | dibenz[a,h]anthracene | increases expression | ISO | RGD:1617378 | 6480464 | 1 more ... | CTD | PMID:26377693 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PCDH17 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of PCDH17 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | RGD:1617378 | 6480464 | Ethanol affects the splicing of PCDH17 mRNA | CTD | PMID:30319688 | ethanol | increases expression | ISO | RGD:1617378 | 6480464 | Ethanol results in increased expression of PCDH17 mRNA | CTD | PMID:30319688 | medroxyprogesterone acetate | decreases expression | EXP | | 6480464 | Medroxyprogesterone Acetate results in decreased expression of PCDH17 mRNA | CTD | PMID:20843944 | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of PCDH17 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of PCDH17 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | RGD:1617378 | 6480464 | Miconazole results in decreased expression of PCDH17 mRNA | CTD | PMID:27462272 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PCDH17 mRNA | CTD | PMID:24810058 | N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:1304753 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of PCDH17 mRNA | CTD | PMID:28801915 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:1617378 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | N-nitrosodiethylamine | increases expression | ISO | RGD:1617378 | 6480464 | Diethylnitrosamine results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | paracetamol | affects expression | ISO | RGD:1617378 | 6480464 | Acetaminophen affects the expression of PCDH17 mRNA | CTD | PMID:17562736 | phenobarbital | multiple interactions | ISO | RGD:1617378 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA | CTD | PMID:24535843 | pirinixic acid | increases expression | ISO | RGD:1617378 | 6480464 | pirinixic acid results in increased expression of PCDH17 mRNA | CTD | PMID:18301758, PMID:23811191 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of PCDH17 mRNA | CTD | PMID:22714537 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of PCDH17 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA | CTD | PMID:27188386 | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of PCDH17 gene | CTD | PMID:28589171 | sodium fluoride | decreases expression | ISO | RGD:1617378 | 6480464 | Sodium Fluoride results in decreased expression of PCDH17 mRNA | CTD | PMID:27862939 | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of PCDH17 mRNA | CTD | PMID:11906190 | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of PCDH17 mRNA | CTD | PMID:17440010 | tetraphene | multiple interactions | ISO | RGD:1617378 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA | CTD | PMID:27858113 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of PCDH17 mRNA | CTD | PMID:19695317 | titanium dioxide | increases expression | ISO | RGD:1617378 | 6480464 | titanium dioxide results in increased expression of PCDH17 mRNA | CTD | PMID:23557971 | titanium dioxide | decreases expression | ISO | RGD:1617378 | 6480464 | titanium dioxide results in decreased expression of PCDH17 mRNA | CTD | PMID:23409001 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of PCDH17 mRNA | CTD | PMID:24935251 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of PCDH17 mRNA | CTD | PMID:24935251 | trimellitic anhydride | decreases expression | ISO | RGD:1617378 | 6480464 | trimellitic anhydride results in decreased expression of PCDH17 mRNA | CTD | PMID:19042947 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PCDH17 mRNA | CTD | PMID:24383497 | valproic acid | affects splicing | ISO | RGD:1304753 | 6480464 | Valproic Acid affects the splicing of PCDH17 mRNA | CTD | PMID:29427782 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PCDH17 mRNA | CTD | PMID:19101580 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PCDH17 mRNA | CTD | PMID:25979313 | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of PCDH17 mRNA | CTD | PMID:24714768 | |
|
|
|
|
|
|
|
|
|
|
1. | GOA_HUMAN data from the GO Consortium |
2. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | RGD automated import pipeline for gene-chemical interactions |
PubMed | 10716726 10817752 10835267 11082270 12477932 14702039 15057823 15342556 15489334 15604093 15905963 16344560 16713569 17464717 17672918 17978184 18353903 18718692 19449025 19945174 20180417 20200074 21213369 21873635 22207556 22589738 22926751 23684785 24366498 24567353 26386721 26404644 26683656 26700620 27351130 27643535 28070120 28514442 28688232 29566279 29676528 29991130 30165032 30213786 |
PCDH17 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pcdh17 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pcdh17 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pcdh17 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCDH17 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCDH17 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pcdh17 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCDH17 (Sus scrofa - pig) |
|
D13S1303 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WI-18283 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH44773 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-30612 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCDH17_1260 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-56621 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
G20769 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A006F33 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-33151 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOC144997 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCDH17 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001040429 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
XM_005266357 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_005266358 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017020547 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AF029343 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AK001134 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK289980 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK307545 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL137503 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL137505 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL445216 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL445288 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC028165 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BF511144 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BP286383 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471124 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DA458702 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001040429 ⟹ NP_001035519 | |||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | |||||||||||||||||||||||||||||
Type: | CODING | |||||||||||||||||||||||||||||
Position: |
|
|||||||||||||||||||||||||||||
Sequence: |
GATTTCGGGGGAGAGCCTTTTCCGAGGAAGAGAGGGAGGAGCCTGGTGGGGAGAGGAAACTACAhide sequence |
RefSeq Acc Id: | XM_005266357 ⟹ XP_005266414 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
AGTCAGTCAGCAAGAGACGCTGGGGAGAGAGCAGGGATCGCGAGCCCGGCGGATGCGGCAGCGGhide sequence |
RefSeq Acc Id: | XM_005266358 ⟹ XP_005266415 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
AGTCAGTCAGCAAGAGACGCTGGGGAGAGAGCAGGGATCGCGAGCCCGGCGGATGCGGCAGCGGhide sequence |
RefSeq Acc Id: | XM_017020547 ⟹ XP_016876036 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AGTCAGTCAGCAAGAGACGCTGGGGAGAGAGCAGGGATCGCGAGCCCGGCGGATGCGGCAGCGGhide sequence |
Protein RefSeqs | NP_001035519 | (Get FASTA) | NCBI Sequence Viewer |
XP_005266414 | (Get FASTA) | NCBI Sequence Viewer | |
XP_005266415 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016876036 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAB84144 | (Get FASTA) | NCBI Sequence Viewer |
AAH28165 | (Get FASTA) | NCBI Sequence Viewer | |
BAF82669 | (Get FASTA) | NCBI Sequence Viewer | |
EAW52059 | (Get FASTA) | NCBI Sequence Viewer | |
EAW52060 | (Get FASTA) | NCBI Sequence Viewer | |
EAW52061 | (Get FASTA) | NCBI Sequence Viewer | |
O14917 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_001035519 ⟸ NM_001040429 |
- Peptide Label: | precursor |
- UniProtKB: | O14917 (UniProtKB/Swiss-Prot) |
- Sequence: |
MYLSICCCFLLWAPALTLKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYhide sequence |
RefSeq Acc Id: | XP_005266415 ⟸ XM_005266358 |
- Peptide Label: | isoform X2 |
- Sequence: |
MYLSICCCFLLWAPALTLKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYhide sequence |
RefSeq Acc Id: | XP_005266414 ⟸ XM_005266357 |
- Peptide Label: | isoform X1 |
- UniProtKB: | O14917 (UniProtKB/Swiss-Prot) |
- Sequence: |
MYLSICCCFLLWAPALTLKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYhide sequence |
RefSeq Acc Id: | XP_016876036 ⟸ XM_017020547 |
- Peptide Label: | isoform X3 |
- Sequence: |
MYLSICCCFLLWAPALTLKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYhide sequence |
RGD ID: | 6790997 | |||||||||
Promoter ID: | HG_KWN:17991 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | HeLa_S3 | |||||||||
Transcripts: | OTTHUMT00000045139, OTTHUMT00000045140, UC010AEC.1 | |||||||||
Position: |
|
RGD ID: | 6791013 | |||||||||
Promoter ID: | HG_KWN:17992 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | HeLa_S3 | |||||||||
Transcripts: | UC001VHR.1 | |||||||||
Position: |
|
RGD ID: | 7226537 | |||||||||
Promoter ID: | EPDNEW_H19014 | |||||||||
Type: | initiation region | |||||||||
Name: | PCDH17_2 | |||||||||
Description: | protocadherin 17 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7226541 | |||||||||
Promoter ID: | EPDNEW_H19015 | |||||||||
Type: | initiation region | |||||||||
Name: | PCDH17_1 | |||||||||
Description: | protocadherin 17 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 13q12.3-31.3(chr13:31363472-90575292)x3 | copy number gain | Scoliosis [RCV000050293]|See cases [RCV000050293] | Chr13:31363472..90575292 [GRCh38] Chr13:31937609..91227546 [GRCh37] Chr13:30835609..90025547 [NCBI36] Chr13:13q12.3-31.3 |
pathogenic |
GRCh38/hg38 13q14.12-31.3(chr13:44967523-92738168)x1 | copy number loss | Omphalocele [RCV000050891]|See cases [RCV000050891] | Chr13:44967523..92738168 [GRCh38] Chr13:45541658..93390421 [GRCh37] Chr13:44439658..92188422 [NCBI36] Chr13:13q14.12-31.3 |
pathogenic |
GRCh38/hg38 13q12.3-21.33(chr13:30697728-69471973)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051373]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051373]|See cases [RCV000051373] | Chr13:30697728..69471973 [GRCh38] Chr13:31271865..70046105 [GRCh37] Chr13:30169865..68944106 [NCBI36] Chr13:13q12.3-21.33 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:18946182-114304628)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053726]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053726]|See cases [RCV000053726] | Chr13:18946182..114304628 [GRCh38] Chr13:19520322..115070103 [GRCh37] Chr13:18418322..114088205 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053731]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053731]|See cases [RCV000053731] | Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q12.3-31.1(chr13:30318913-83610426)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053737]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053737]|See cases [RCV000053737] | Chr13:30318913..83610426 [GRCh38] Chr13:30893050..84184561 [GRCh37] Chr13:29791050..83082562 [NCBI36] Chr13:13q12.3-31.1 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18565048-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053719]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053719]|See cases [RCV000053719] | Chr13:18565048..114327173 [GRCh38] Chr13:19139188..115085141 [GRCh37] Chr13:18037188..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18850545-114327173)x3 | copy number gain | Premature Birth [RCV000053723]|See cases [RCV000053723] | Chr13:18850545..114327173 [GRCh38] Chr13:19296527..115085141 [GRCh37] Chr13:18194527..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q13.2-34(chr13:33528097-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053759]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053759]|See cases [RCV000053759] | Chr13:33528097..114327173 [GRCh38] Chr13:34102234..115085141 [GRCh37] Chr13:33000234..114110750 [NCBI36] Chr13:13q13.2-34 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:43219125-114327314)x3 | copy number gain | Polydactyly [RCV000053762]|See cases [RCV000053762] | Chr13:43219125..114327314 [GRCh38] Chr13:43793261..115085141 [GRCh37] Chr13:42691261..114110891 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:44164751-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053764]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053764]|See cases [RCV000053764] | Chr13:44164751..114327173 [GRCh38] Chr13:44738887..115085141 [GRCh37] Chr13:43636887..114110750 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q14.12-34(chr13:44733046-114327173)x3 | copy number gain | Nonsyndromic microcephaly [RCV000053767]|See cases [RCV000053767] | Chr13:44733046..114327173 [GRCh38] Chr13:45307182..115085141 [GRCh37] Chr13:44205182..114110750 [NCBI36] Chr13:13q14.12-34 |
pathogenic |
NM_001040429.2(PCDH17):c.3270C>T (p.Phe1090=) | single nucleotide variant | Malignant melanoma [RCV000070394] | Chr13:57725084 [GRCh38] Chr13:58299218 [GRCh37] Chr13:57197219 [NCBI36] Chr13:13q21.1 |
not provided |
NM_001040429.2(PCDH17):c.3005G>A (p.Gly1002Glu) | single nucleotide variant | Malignant melanoma [RCV000062689] | Chr13:57724819 [GRCh38] Chr13:58298953 [GRCh37] Chr13:57196954 [NCBI36] Chr13:13q21.1 |
not provided |
GRCh38/hg38 13q13.3-21.31(chr13:36777318-62955876)x1 | copy number loss | See cases [RCV000133696] | Chr13:36777318..62955876 [GRCh38] Chr13:37351455..63530009 [GRCh37] Chr13:36249455..62428010 [NCBI36] Chr13:13q13.3-21.31 |
pathogenic |
GRCh38/hg38 13q14.11-31.1(chr13:41288493-85137552)x3 | copy number gain | See cases [RCV000133944] | Chr13:41288493..85137552 [GRCh38] Chr13:41862629..85711687 [GRCh37] Chr13:40760629..84609688 [NCBI36] Chr13:13q14.11-31.1 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19833130-114298614)x3 | copy number gain | See cases [RCV000134104] | Chr13:19833130..114298614 [GRCh38] Chr13:20407270..115064089 [GRCh37] Chr13:19305270..114082191 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q12.3-21.32(chr13:31553608-65470367)x3 | copy number gain | See cases [RCV000135808] | Chr13:31553608..65470367 [GRCh38] Chr13:32127745..66044499 [GRCh37] Chr13:31025745..64942500 [NCBI36] Chr13:13q12.3-21.32 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18445862-114327173)x1 | copy number loss | See cases [RCV000135610] | Chr13:18445862..114327173 [GRCh38] Chr13:19020001..115085141 [GRCh37] Chr13:10098739..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q14.11-31.1(chr13:41143820-85137552)x1 | copy number loss | See cases [RCV000136526] | Chr13:41143820..85137552 [GRCh38] Chr13:41717956..85711687 [GRCh37] Chr13:40615956..84609688 [NCBI36] Chr13:13q14.11-31.1 |
pathogenic |
GRCh38/hg38 13q14.2-31.1(chr13:47117587-84300935)x1 | copy number loss | See cases [RCV000136647] | Chr13:47117587..84300935 [GRCh38] Chr13:47691722..84875070 [GRCh37] Chr13:46589723..83773071 [NCBI36] Chr13:13q14.2-31.1 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:40942298-114340331)x1 | copy number loss | See cases [RCV000137893] | Chr13:40942298..114340331 [GRCh38] Chr13:41516434..115085141 [GRCh37] Chr13:40414434..114123908 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q13.1-31.1(chr13:32531486-86757044)x3 | copy number gain | See cases [RCV000138339] | Chr13:32531486..86757044 [GRCh38] Chr13:33105623..87409299 [GRCh37] Chr13:32003623..86207300 [NCBI36] Chr13:13q13.1-31.1 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19833130-114327106)x3 | copy number gain | See cases [RCV000139078] | Chr13:19833130..114327106 [GRCh38] Chr13:20407270..115085141 [GRCh37] Chr13:19305270..114110683 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18456040-114340285)x3 | copy number gain | See cases [RCV000140004] | Chr13:18456040..114340285 [GRCh38] Chr13:19030180..115105760 [GRCh37] Chr13:17928180..114123862 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q21.1(chr13:54988722-57837457)x1 | copy number loss | See cases [RCV000140719] | Chr13:54988722..57837457 [GRCh38] Chr13:55562857..58411591 [GRCh37] Chr13:54460858..57309592 [NCBI36] Chr13:13q21.1 |
uncertain significance |
GRCh38/hg38 13q13.3-21.32(chr13:37864226-67963788)x1 | copy number loss | See cases [RCV000140744] | Chr13:37864226..67963788 [GRCh38] Chr13:38438363..68537920 [GRCh37] Chr13:37336363..67435921 [NCBI36] Chr13:13q13.3-21.32 |
pathogenic |
GRCh38/hg38 13q21.1-21.31(chr13:55851510-63770251)x1 | copy number loss | See cases [RCV000142460] | Chr13:55851510..63770251 [GRCh38] Chr13:56425644..64344384 [GRCh37] Chr13:55323645..63242385 [NCBI36] Chr13:13q21.1-21.31 |
uncertain significance |
GRCh38/hg38 13q14.2-21.31(chr13:47765202-62058520)x1 | copy number loss | See cases [RCV000142223] | Chr13:47765202..62058520 [GRCh38] Chr13:48339337..62632653 [GRCh37] Chr13:47237338..61530654 [NCBI36] Chr13:13q14.2-21.31 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19671934-114340331)x3 | copy number gain | See cases [RCV000142924] | Chr13:19671934..114340331 [GRCh38] Chr13:20246074..115085141 [GRCh37] Chr13:19144074..114123908 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18862146-114342258)x3 | copy number gain | See cases [RCV000143462] | Chr13:18862146..114342258 [GRCh38] Chr13:19436286..115107733 [GRCh37] Chr13:18334286..114125835 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q12.3-31.3(chr13:31363472-90575292)x3 | copy number gain | See cases [RCV000148244] | Chr13:31363472..90575292 [GRCh38] Chr13:31937609..91227546 [GRCh37] Chr13:30835609..90025547 [NCBI36] Chr13:13q12.3-31.3 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3 | copy number gain | See cases [RCV000148126] | Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh37/hg19 13q12.11-34(chr13:19571503-115092569)x3 | copy number gain | See cases [RCV000240150] | Chr13:19571503..115092569 [GRCh37] Chr13:13q12.11-34 |
pathogenic |
GRCh37/hg19 13q21.1-21.33(chr13:56987542-69758302)x3 | copy number gain | See cases [RCV000449267] | Chr13:56987542..69758302 [GRCh37] Chr13:13q21.1-21.33 |
pathogenic |
GRCh37/hg19 13q14.3-33.3(chr13:53551300-109850651)x1 | copy number loss | See cases [RCV000449272] | Chr13:53551300..109850651 [GRCh37] Chr13:13q14.3-33.3 |
pathogenic |
GRCh37/hg19 13q21.1(chr13:58288521-58432447)x1 | copy number loss | See cases [RCV000449174] | Chr13:58288521..58432447 [GRCh37] Chr13:13q21.1 |
uncertain significance |
GRCh37/hg19 13q12.11-34(chr13:19571503-115092510) | copy number gain | See cases [RCV000449142] | Chr13:19571503..115092510 [GRCh37] Chr13:13q12.11-34 |
pathogenic |
GRCh37/hg19 13q14.11-31.3(chr13:42457841-91796698)x1 | copy number loss | See cases [RCV000446747] | Chr13:42457841..91796698 [GRCh37] Chr13:13q14.11-31.3 |
pathogenic |
GRCh37/hg19 13q13.1-21.31(chr13:32946120-62698217)x1 | copy number loss | See cases [RCV000446067] | Chr13:32946120..62698217 [GRCh37] Chr13:13q13.1-21.31 |
pathogenic |
GRCh37/hg19 13q21.1-34(chr13:56431743-115107733) | copy number gain | See cases [RCV000510722] | Chr13:56431743..115107733 [GRCh37] Chr13:13q21.1-34 |
pathogenic |
GRCh37/hg19 13q11-34(chr13:19436286-115107733)x3 | copy number gain | See cases [RCV000445886] | Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q11-34(chr13:19436287-115107733) | copy number gain | See cases [RCV000510405] | Chr13:19436287..115107733 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q11-34(chr13:19436287-115107733)x3 | copy number gain | See cases [RCV000511880] | Chr13:19436287..115107733 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q14.3-32.1(chr13:53932358-96586363)x3 | copy number gain | See cases [RCV000512571] | Chr13:53932358..96586363 [GRCh37] Chr13:13q14.3-32.1 |
pathogenic |
GRCh37/hg19 13q14.3-21.32(chr13:51939350-66854666)x3 | copy number gain | not provided [RCV000683569] | Chr13:51939350..66854666 [GRCh37] Chr13:13q14.3-21.32 |
likely pathogenic |
GRCh37/hg19 13q21.1(chr13:56519744-58546632)x1 | copy number loss | not provided [RCV000683552] | Chr13:56519744..58546632 [GRCh37] Chr13:13q21.1 |
likely benign |
GRCh37/hg19 13q21.1-21.2(chr13:55639124-60081983)x1 | copy number loss | not provided [RCV000683562] | Chr13:55639124..60081983 [GRCh37] Chr13:13q21.1-21.2 |
uncertain significance |
GRCh37/hg19 13q11-22.1(chr13:19436286-74045459)x3 | copy number gain | not provided [RCV000683572] | Chr13:19436286..74045459 [GRCh37] Chr13:13q11-22.1 |
pathogenic |
NC_000013.11:g.46968080_87381985del40413906 | deletion | 13q partial monosomy syndrome [RCV000721955] | Chr13:46968080..87381985 [GRCh38] Chr13:13q14.2-31.2 |
pathogenic |
GRCh37/hg19 13q11-34(chr13:19058717-115103529)x3 | copy number gain | not provided [RCV000738115] | Chr13:19058717..115103529 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q21.1(chr13:58233322-58259492)x1 | copy number loss | not provided [RCV000738210] | Chr13:58233322..58259492 [GRCh37] Chr13:13q21.1 |
benign |
GRCh37/hg19 13q11-34(chr13:19031237-115107157)x3 | copy number gain | not provided [RCV000750643] | Chr13:19031237..115107157 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q21.1-31.3(chr13:57058434-94684615)x1 | copy number loss | not provided [RCV000750731] | Chr13:57058434..94684615 [GRCh37] Chr13:13q21.1-31.3 |
pathogenic |
GRCh37/hg19 13q14.3-21.31(chr13:54638436-63254336)x3 | copy number gain | See cases [RCV000790596] | Chr13:54638436..63254336 [GRCh37] Chr13:13q14.3-21.31 |
uncertain significance |
GRCh37/hg19 13q11-34(chr13:19436286-115107733)x3 | copy number gain | not provided [RCV000849129] | Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34 |
pathogenic |
GRCh37/hg19 13q14.2-21.2(chr13:49586017-61311845)x1 | copy number loss | not provided [RCV000846575] | Chr13:49586017..61311845 [GRCh37] Chr13:13q14.2-21.2 |
uncertain significance |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:14267 | AgrOrtholog |
COSMIC | PCDH17 | COSMIC |
Ensembl Genes | ENSG00000118946 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000367151 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000432899 | UniProtKB/Swiss-Prot | |
ENSP00000481329 | UniProtKB/TrEMBL | |
ENSP00000483215 | UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000377918 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000484979 | UniProtKB/Swiss-Prot | |
ENST00000612954 | UniProtKB/TrEMBL | |
ENST00000615375 | UniProtKB/TrEMBL | |
GTEx | ENSG00000118946 | GTEx |
HGNC ID | HGNC:14267 | ENTREZGENE |
Human Proteome Map | PCDH17 | Human Proteome Map |
InterPro | Cadherin-like_dom | UniProtKB/Swiss-Prot |
Cadherin-like_sf | UniProtKB/Swiss-Prot | |
Cadherin_CS | UniProtKB/Swiss-Prot | |
Cadherin_N | UniProtKB/Swiss-Prot | |
Protocadherin-17 | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:27253 | UniProtKB/Swiss-Prot |
NCBI Gene | 27253 | ENTREZGENE |
OMIM | 611760 | OMIM |
PANTHER | PTHR24028:SF41 | UniProtKB/Swiss-Prot |
Pfam | Cadherin | UniProtKB/Swiss-Prot |
Cadherin_2 | UniProtKB/Swiss-Prot | |
PharmGKB | PA33001 | PharmGKB |
PRINTS | CADHERIN | UniProtKB/Swiss-Prot |
PROSITE | CADHERIN_1 | UniProtKB/Swiss-Prot |
CADHERIN_2 | UniProtKB/Swiss-Prot | |
SMART | SM00112 | UniProtKB/Swiss-Prot |
Superfamily-SCOP | SSF49313 | UniProtKB/Swiss-Prot |
UniGene | Hs.106511 | ENTREZGENE |
UniProt | A0A087WXV2_HUMAN | UniProtKB/TrEMBL |
A0A087X099_HUMAN | UniProtKB/TrEMBL | |
O14917 | ENTREZGENE, UniProtKB/Swiss-Prot | |
UniProt Secondary | A8K1R5 | UniProtKB/Swiss-Prot |
Q5VVW9 | UniProtKB/Swiss-Prot | |
Q5VVX0 | UniProtKB/Swiss-Prot |
![]() |
More on PCDH17 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1312379 |
Created: | 2005-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.